Tickerplace logo

Tickerplace

Royalty Pharma plc logo

RPRXRoyalty Pharma plc

RPRX Stock Price, Valuation & Chart | Royalty Pharma plc

Compare
$61.310+0.73 (+1.21%)

At close · 21 Aug 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyRPRX intrinsic valueIs RPRX overvalued or undervalued
OverviewFinancialsDividendsRatios

RPRX Historical price chart

RPRX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization27.18B
PE Ratio11.68
EPS5.25
Trading Volume2.26M
Today's High/Low61.55/60.53
Dividend Yield1.51
52 Week High/Low62.13/34.08
Shares Outstanding443.27M
RPRX Financial Statement
RPRX Analyst ratings
RPRX Analysis & performance metrics

RPRX Company profile

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved…

RPRX Management team

Management
James Folmar Reddoch Ph.D.
Executive Vice President of Investments & Chief Scientific Officer
Eric Cornelius SchneiderCTO
Senior Vice President & Chief Technology Officer
Kristin Stafford
Senior Vice President & Chief Accounting Officer
Ashwin Pai M.D.
Executive Vice President of Investments
Christopher Hite
Vice Chairman & Executive Vice President
Pablo Gerardo LegorretaCEO
Founder, Chairman of the Board & Chief Executive Officer
Marshall Jonathan Urist M.D., Ph.D.
Executive Vice President of Research & Investments
Arthur Richard McGivern J.D.
Executive Vice President of Investments & General Counsel
Total 8 executives

RPRX Frequently asked questions

What is Royalty Pharma plc (RPRX) Stock Price?

Current stock price of Royalty Pharma plc (RPRX) stock is $61.310. The stock price is +1.21% higher in the session. The intraday range can be seen from this page. Volume of Royalty Pharma plc (RPRX) stock is 2.26M.

Last updated at 21 Aug 2026, 08:00 pm.

Why is the Royalty Pharma plc (RPRX) stock price going up or down today?

The stock price of Royalty Pharma plc (RPRX) can change with earnings, company news, and overall market sentiment. Royalty Pharma plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Royalty Pharma plc stock expensive at its current price?

Whether Royalty Pharma plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RPRX on this page is 11.68. EPS on this page is 5.25. Compare those figures with peers and growth expectations before deciding if the current Royalty Pharma plc price is justified.

How has the stock price of Royalty Pharma plc (RPRX) performed historically?

Historical performance for Royalty Pharma plc (RPRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RPRX reacted to past earnings and market events.

Should I buy Royalty Pharma plc (RPRX) stock, at this price?

Buying Royalty Pharma plc (RPRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.